Brentuximab vedotin demonstrates objective responses in a phase 2 study of relapsed/refractory DLBCL with variable CD30 expression
| Autor: | Jacobsen, Eric D. *, Sharman, Jeff P., Oki, Yasuhiro, Advani, Ranjana H., Winter, Jane N., Bello, Celeste M., Spitzer, Gary, Palanca-Wessels, Maria Corinna, Kennedy, Dana A., Levine, Pamela, Yang, Jing, Bartlett, Nancy L. |
|---|---|
| Zdroj: | In Blood 26 February 2015 125(9):1394-1402 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|